Mereo BioPharma Group PLC ADR (MREO)
Mereo BioPharma Group PLC ADR (MREO) is a NASDAQ-listed American depositary receipt tied to Mereo BioPharma Group plc common stock. This security context identifies it as an ADR or depositary receipt rather than ordinary U.S. equity. Mereo BioPharma Group PLC ADR is classified in the healthcare sector and biotechnology industry. The underlying company is associated with biopharmaceutical research and development, with an emphasis on therapies for serious and rare conditions. As a depositary receipt, the instrument represents foreign shares and provides U.S. market access to the issuer through the NASDAQ exchange.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MREO
|
$0.33
|
3.1% Upside
|
Fair
|
$1.98
|
525.8% Upside
|
Bargain
|
Weak
|
0.0%
|
November 17, 2026
|
1.6x
|
50.51 M
|
17.194 M
|
2.2%
|
78.3%
|
-41.6
|
90.2%
|
